Viridian Therapeutics Stock Forecast

Stock Price Forecast

The 9 analysts with 12-month price forecasts for Viridian Therapeutics stock have an average target of 36.44, with a low estimate of 20 and a high estimate of 61. The average target predicts an increase of 169.13% from the current stock price of 13.54.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$20	$36.44	$34	$61
Change	+47.71%	+169.13%	+151.11%	+350.52%

* Price targets were last updated on Jan 7, 2025.

Analyst Ratings

The average analyst rating for Viridian Therapeutics stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	4	5	5	5	5	5
Buy	5	4	4	4	4	4
Hold	2	2	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	12	12	12	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Serge Belanger Needham	Needham	Strong Buy Reiterates $38	Strong Buy	Reiterates	$38	+180.65%	Jan 7, 2025
Derek Archila Wells Fargo	Wells Fargo	Buy → Hold Downgrades $27	Buy → Hold	Downgrades	$27	+99.41%	Dec 19, 2024
Gregory Renza RBC Capital	RBC Capital	Buy Maintains $44 → $47	Buy	Maintains	$44 → $47	+247.12%	Dec 17, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $34	Strong Buy	Reiterates	$34	+151.11%	Dec 17, 2024
Douglas Tsao HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $34	Strong Buy	Reiterates	$34	+151.11%	Dec 16, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

230.99K

from 302.00K

-23.51%

from 302.00K

Revenue Next Year

40.95M

from 230.99K

17,629.40%

from 230.99K

EPS This Year

-4.31

from -3.07

EPS Next Year

-4.14

from -4.31

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	1.05M	2.96M	1.77M	314.00K	302.00K	230.99K	40.95M	316.76M
Revenue Growth	-76.46%	182.19%	-40.20%	-82.28%	-3.82%	-23.51%	17,629.40%	673.47%
EPS	-31.13	-6.66	-2.71	-3.91	-3.07	-4.31	-4.14	-2.11
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	17	13	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	1.1M	96.9M	1.0B
Avg	230,989	41.0M	316.8M
Low	n/a	n/a	102.9M

Revenue Growth

Revenue Growth	2025	2026	2027
High	247.7%	41,856.5%	2,415.1%
Avg	-23.5%	17,629.4%	673.5%
Low	-	-	151.2%

EPS Forecast

EPS	2025	2026	2027
High	-3.33	-2.44	0.36
Avg	-4.31	-4.14	-2.11
Low	-5.79	-6.39	-3.60

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.